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Abstract
Paramyxoviruses are responsible for a wide variety of diseases both in humans and in animals.
Common to many paramyxoviruses is the fact that they can cause neurological symptoms in
their final host. Newly discovered paramyxoviruses, such as the Hendra and Nipah viruses,
show the same pattern of pathogenesis as that of the paramyxoviruses already known.
Canine distemper virus (CDV) is a well-studied member of the genus Morbillivirus. Study of
the neuropathogenesis of CDV might give insight into disease mechanisms and suggest
approaches for the prevention of other recently discovered paramyxovirus infections.
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Introduction
Members of the family Paramyxoviridae are responsible
for a variety of important diseases affecting livestock
(e.g. rinderpest, Newcastle disease), pet animals (e.g.
canine distemper) and man (e.g. measles) (Table 1). The
most significant economic losses in livestock are caused
by rinderpest virus and Newcastle disease virus. Canine
distemper is the most important viral disease in dogs,
with high morbidity and mortality in unvaccinated popu-
lations worldwide. In humans, measles continues to be a
significant cause of infant mortality in developing coun-
tries. Also, in industrialized countries, outbreaks of
importance are occasionally observed in children, prob-
ably as a result of inadequate vaccination programs.
During the past two decades, several novel paramyx-
oviruses have emerged (such as Hendra, Nipah and
phocine distemper virus) and several previously
described paramyxoviruses [such as canine distemper
virus (CDV)] have crossed the species barrier. Many of
these newer and older members of the family
Paramyxoviridae can cause neurological symptoms
because of invasion of virus and/or immune cells into
the central nervous system (CNS). The detailed studies
of the neuropathogenesis of CDV that have been carried
out might therefore give some insight into similar dis-
ease patterns among the emerging paramyxoviruses.
This review provides a brief summary of our knowledge
of important emerging paramyxoviruses and of the
pathogenesis of CDV in dogs.
Henipah, a new genus in the family Paramyxoviridae
Recently, a new group of paramyxoviruses closely
related but distinct from the genus Morbillivirus has
been discovered. These viruses, which were first identi-
fied in Australia (Hendra) and Malaysia (Nipah), cause
subclinical infection in fruit bats, and have caused mor-
tality in horses, pigs and humans. Both viruses were
initially classified as Morbillivirus-like, but will now be
assigned to a new genus, Henipah, within the paramyx-
ovirus family (Mayo, 2002) (Tables 1 and 2).
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In September 1994, a sudden outbreak due to a previ-
ously unknown agent caused the deaths of 13 horses
and a human due to a hyperacute respiratory disease
with mild neurological symptoms. Subsequently, another
outbreak was recorded in a single horse in Cairns
(Australia) in 1999 (for review see Barclay and Paton,
2000; Hooper and Williamson, 2000; Mackenzie et al.,
2001; Wang and Eaton, 2001). The virus is not highly
contagious since transmission from horses to other
horses and to humans occurs only after very close con-
tact with an infected individual. Serological studies have
shown that other species, such as dogs, cats and live-
stock species, have not been infected by the virus so far.
The causative agent was initially called ‘equine morbil-
livirus’, but subsequent genetic analyses showed that its
most appropriate classification is as the prototype mem-
ber of a new genus within the family Paramyxoviridae
(Murray et al., 1995, 1998; Rogers et al., 1996; O’Sullivan
et al., 1997; Chua et al., 2000; Harcourt et al., 2000;
Wang et al., 2000; Mayo 2002).
Although it had been presumed that Nipah virus had
caused a low level of mortality in pigs in Malaysia since
1996, the virus remained unknown until September
1998, when a major outbreak in humans and pigs
resulted in over 265 infected humans, 105 of whom died
of encephalitis, and the slaughter of over 1.2 million
pigs since then. In contrast to Hendra virus, Nipah virus
was found to be contagious and the authorities were
forced to choose culling as the only option to control
the spread of the virus (Chua et al., 1999, 2000, 2002;
Mackenzie et al., 2001). Unlike the respiratory disease
caused by Hendra virus in horses, Nipah virus infection
in pigs led to subclinical infection with mild respiratory
symptoms and occasional CNS involvement (Table 2). In
humans, Nipah virus infected the CNS and caused
encephalitis and death (Lam et al., 2002). In contrast to
Hendra virus, Nipah virus appears to be able to infect
other animals, such as dogs, rats, and even a variety of
avian species. The introduction of intensive pig farming
in areas where the fruit bat is present as a vector was
probably the direct cause of the appearance of Nipah
virus in pigs. Recent studies even suggest that Nipah
virus is more widespread in Southeast Asia than previ-
ously documented (Olson et al., 2002).
The detailed molecular characteristics of both Hendra
and Nipah virus have been published (for review see
Wang and Eaton, 2001). In summary, Hendra and Nipah
viruses resemble respiroviruses and morbilliviruses
more closely than rubellaviruses. However, they have
features that make them unique and distinct and there-
fore justify classification as a new genus within the
family Paramyxoviridae, Henipah (Wang and Eaton,
2001). Since Hendra and Nipah are zoonotic viruses, it
needs to be pointed out that work with these viruses
must be carried out strictly in approved biosafety level
4 laboratories.
In addition, there are several other viruses not yet
assigned to the paramyxovirus family. Menangle virus
was isolated in 1997 from piglets in Australia, and two
humans seroconverted after having close contact with
the infected animals. It is likely, with increasing dis-
ease awareness and surveillance, that new viruses of
the family Paramyxoviridae will be found in other
species.
2 Christian Griot et al.
Table 1. Examples of the family Paramyxoviridae
Genus Virus Host Re-emerging and/or Vaccination2
emerging
Respirovirus Parainfluenza 1–3 Mammals No Yes
Paramyxovirus Pig Yes Yes
Morbillivirus Measles Human Yes Yes3
Canine distemper Carnivores, Yes Yes
seal
Phocid distemper1 Seal Yes No
Dolphin morbillivirus Dolphin Yes No
Rinderpest Cattle No Yes
Peste des petites ruminantes Sheep, goat No Yes
Rubellavirus Mumps Human No Yes
Newcastle disease Fowl No Yes
Pneumovirus Bovine respiratory Cattle No Yes
syncytial
Metapneumovirus Turkey rhinotracheitis Turkey Yes Yes
Henipah Hendra Horse, human5 Yes No
Nipah Pig, human5 Yes No4
Unassigned Menangle Pig, human5 Yes No
1Also called phocine distemper virus; 2common vaccination practice; 3vaccination coverage in certain areas, population
groups rather poor; 4experimental vaccine (T. McKenna, personal communication), 5fruit bat reservoir, modified after Wang
and Eaton, 2001.
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Morbilliviruses of carnivores and aquatic mammals
CDV is the only member of the genus Morbillivirus,
which in the past has been associated with disease in a
wide range of carnivores. In the past two decades, how-
ever, CDV has crossed the species barrier on several
occasions and has caused significant problems after its
introduction into a new species. Many aspects of CDV,
including its molecular biology, diagnosis, host range
and epidemiology, have been reviewed in earlier publi-
cations (Vandevelde and Zurbriggen, 1995; Stettler et al.,
1997; Barrett, 1999; Cherpillod et al., 1999; Leisewitz et
al., 2001; Deem et al., 2000) and will not be discussed
here.
Although live attenuated vaccines have been used
successfully for many years to control morbillivirus dis-
eases, canine distemper continues to be a problem,
outbreaks occurring in domestic dogs and farmed mink
populations. The current vaccines on the market have
some severe drawbacks. It was suggested earlier that the
insufficient protection provided by the vaccine strains
might be the consequence of changes occurring in the
vaccine virus after cell culture passages (Stettler and
Zurbriggen, 1995; Bolt et al., 1997; Iwatsuki et al., 1997).
Other side-effects of vaccination are (i) the potential
induction of immunosuppression, (ii) CNS complications
(Hartley, 1974; Cornwell et al., 1988), (iii) mortality in
species other than carnivores (Bush et al., 1976;
Carpenter et al., 1976; Barrett, 1999), and (iv) occasional
insufficient protection (Johnson et al., 1995; Gemma et
al., 1996; Ek-Kommonen et al., 1997).
Besides the known susceptible species in the order
Carnivora, CDV has found many other hosts in past years,
and can therefore be classified as an emerging virus in
these new target species. For example, CDV was isolated
from the African wild dog (van de Bildt et al., 2002), the
Caspian seal (Kennedy et al., 2000) and the Baikal seal
(Osterhaus et al., 1989) (Table 2). Seroprevalence to CDV
has also been shown in the family Felidae, in particular
the Serengeti lion (Morell, 1996; Roelke-Parker et al.,
1996; Cleaveland et al., 2000) and domestic cats in Japan
and Taiwan (Ikeda et al., 2001). Therefore, alternative
vaccines, such as DNA vaccines, and vaccine delivery sys-
tems (ISCOMS) for CDV (and other members of the
paramyxovirus family) are urgently needed.
In addition, viruses related to CDV have been
described recently: the phocine (seal) distemper virus
(PDV) and the dolphin (Cetacean) morbillivirus (DMV).
PDV was first found in harbor seals in 1988, and led to a
mortality of 50% of the total harbor seal population in
North-Western Europe (Osterhaus et al., 1988; Osterhaus
and Vedder, 1988; Appel et al., 1994; Duignan et al.,
1995; Harder et al., 1995; Brown, 1997). For unknown
reasons, PDV re-emerged in the seal population in sev-
eral countries in Northern Europe in June 2002, and
killed at least 18 000 seals (Jensen et al., 2002). DMV
caused mortality among striped dolphins in the
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Mediterranean Sea and the Gulf of Mexico (Table 2).
This virus is distantly related to PDV and CDV (Barrett et
al., 1993). The epidemiology of these outbreaks remains
mostly obscure. However, factors that have been sug-
gested to be responsible for the emergence of these
viruses in aquatic populations are (i) transmission due to
close contact with distemper-infected dogs and other
carnivores and aquatic mammals infected with the
above-mentioned viruses, and (ii) a weakened immune
system as a result of environmental stress (Barrett, 1999;
Osterhaus 2001; Wang and Eaton, 2001).
Canine distemper in carnivores
CDV is generally transmitted as an aerosol infection of
the upper respiratory tract. The primary replication of the
virus takes place in the lymphoid tissues, leading to
severe, long-lasting immunosuppression (Appel, 1969;
Krakowka et al., 1980; Krakowka, 1982). T cells are more
affected than B cells and CD4+ lymphocytes are rapidly
depleted for several weeks, whereas CD8+ cells are less
affected and recover relatively rapidly. About 10 days
after infection, CDV starts to spread from the sites of pri-
mary replication to various epithelial tissues and the CNS.
As a result of epithelial infection, a variety of respiratory,
intestinal and dermatological signs can occur. The most
serious complication is infection of the CNS, leading to a
variety of neurological symptoms with poor prognosis
(Tipold et al., 1996). Understanding of the mechanisms
by which CDV causes damage to the CNS is important in
the design of new strategies for therapy.
Neuropathology of nervous canine distemper
While some CDV strain variations and related differ-
ences in lesion patterns exist (Summers et al., 1984a), in
the vast majority of cases of spontaneous and experi-
mental distemper with so-called demyelinating strains,
such as R252 (McCullough et al., 1974) and A75/17 CDV
(Summers et al., 1979), the virus causes multifocal
lesions in the gray as well as in the white matter of the
CNS (Summers et al., 1995). The demyelinating lesions
are not only responsible for severe neurological signs
but are also thought to be a model for human demyeli-
nating conditions, such as multiple sclerosis (Appel et
al., 1981; Dal Canto and Rabinowitz, 1982). It has even
been proposed by several groups that, on the basis of
epidemiological and molecular studies, CDV could be
the cause of multiple sclerosis (Krakowka and Koestner,
1978; Cook et al., 1979, 1980, 1986, 1995; Cook and
Dowling, 1980; Hughes et al., 1980; Appel et al., 1981;
Madden et al., 1981; Rohowosky et al., 1995; De Keyser
et al., 2001; Gilden, 2002). Therefore, the pathogenesis
of demyelination in distemper has been investigated
closely in recent years. In the following, we will focus
on the current knowledge of the pathogenesis of
demyelination in canine distemper.
Pathogenesis studies have to consider an acute and a
chronic stage in the development of CDV-induced
demyelination. The initial lesions occur around 3 weeks
after infection and evolve during a period of massive
virus-induced immunosuppression (Vandevelde et al.,
1982a). Depending on the degree and speed of immune
recovery, animals may either become moribund quickly
or recover after developing a mild or subclinical illness.
An intermediate group of animals recovers slowly or
partially, and tends to develop a chronic or relapsing
disease with progression of the demyelinating lesions as
a result of immunopathological reactions (Vandevelde et
al., 1981, 1982b).
The acute stage of CDV-induced demyelination
The initial myelin lesions develop during a period of
severe immunosuppression and are not inflammatory
(Vandevelde et al., 1982a) (Fig. 1). Several immunocyto-
chemical studies and recent in situ hybridization work in
spontaneous and experimental distemper have clearly
shown that demyelination coincides with replication of
CDV in the glial cells of the white matter (Vandevelde et
al., 1985b; Zurbriggen et al., 1993). Spatiotemporal stud-
ies leave no doubt that the initial white matter lesions are
associated with viral activity and that their development
is highly predictable (Summers et al., 1979; Higgins et al.,
1982; Vandevelde et al., 1985b) (Fig. 2). The most obvi-
ous explanation for demyelination would be infection of
oligodendrocytes, the myelin-producing cells.
Therefore, research has focused on evidence of CDV
(mRNA, viral antigen) in oligodendrocytes. At the light
microscope level, it has been shown that the majority of
infected cells are astrocytes (Mutinelli et al., 1989). Most
electron microscope studies agree that oligodendroglial
infection is very rare in distemper (Wisniewski et al.,
4 Christian Griot et al.
Fig. 1. Acute demyelinated region in the cerebellum after nat-
ural canine distemper virus infection. Immunohistochemistry
for myelin basic protein showing oligodendrocytes, the
myelin-producing cells.
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1972; Raine, 1976; Higgins et al., 1982; Summers and
Appel, 1987; Blakemore et al., 1989; Glaus et al., 1990).
Very few oligodendrocytes containing CDV antigen were
found at the light microscope level. However, approxi-
mately 8% of the oligodendrocytes at the edge of lesions
contained CDV mRNA (Zurbriggen et al., 1998). This
restricted infection of oligodendrocytes was found ear-
lier in dog brain cell cultures (DBCC) (Zurbriggen et al.,
1993), in which virulent CDV causes a slowly spreading
non-cytolytic infection. CDV proteins or viral nucleocap-
sids were found only very rarely in oligodendrocytes in
culture, in contrast to astrocytes and microglial cells,
which easily support CDV infection (Vandevelde et al.,
1985a; Zurbriggen et al., 1986, 1987). We conclude from
these studies that CDV causes a restricted infection of
the oligodendrocytes, which is possibly responsible for
the phenomenon of demyelination. Why the production
of viral protein does not take place in these cells
remains to be elucidated.
Between 20 and 30 days after infection, cultured oligo-
dendrocytes, which grow on top of a layer of astrocytes
in mixed DBCC, start to degenerate and disappear,
although the supporting culture remains a continuous
cell sheet (Zurbriggen et al., 1987). Ultrastructural studies
revealed microvacuolation and loss of organelles in such
oligodendrocytes (Glaus et al., 1990). The morphological
changes are preceded by metabolic dysfunction of these
cells, because the activity of cerebroside sulfotrans-
ferase—an oligodendrocyte-specific enzyme—decreased
markedly soon after infection (Glaus et al., 1990) and
myelin transcription is strongly decreased in infected
DBCC (Graber et al., 1995). It was shown in vivo that
CDV infection led to massive down-regulation of myelin
gene transcription, with complete loss of in situ
hybridization for proteolipid protein in oligodendrocytes
within demyelinating lesions (Zurbriggen et al., 1998).
Morphological changes of oligodendrocytes were also
described in the demyelinating lesions in vivo using elec-
tron microscopy (Summers and Appel, 1987; Blakemore
et al., 1989). The fate of the oligodendrocytes remains
unclear, and there is no solid evidence that these cells
undergo necrosis or apoptosis in CDV infection, either in
vivo or in vitro (Schobesberger et al., 1999).
There is little doubt that a change in these cells is at
the root of the demyelinating process, but its mechanism
is not yet understood. It is possible that viral transcrip-
tion taking place in these cells interferes with the
specialized functions necessary to maintain myelin mem-
branes. The possibility that these cells are affected as a
result of virus-induced changes in other cell types can-
not be excluded. However, a series of experiments
could not confirm this hypothesis. Supernatants derived
from CDV-infected DBCC did not induce oligoden-
droglial lesions in recipient dog or mouse brain cell
cultures (Zurbriggen et al., 1987). We were unable to
find evidence of toxic factors, such as tumour necrosis
factor  and reactive oxygen radicals, in the super-
natants of CDV-infected DBCC (Brügger et al., 1992).
Cocultivation of infected DBCC with mouse brain cell
cultures, which are refractory to CDV, did not damage
the mouse oligodendrocytes (unpublished results, C.
Griot and A. Zurbriggen). Likewise, the mouse brain
cells (which remained uninfected in these cocultures)
did not provide protection for the canine oligodendro-
cytes (unpublished results, C. Griot and A. Zurbriggen).
In summary, acute CDV infection of the white matter
results in metabolic oligodendroglial changes, which
lead to demyelination. Whether the change in the oligo-
dendrocytes is the direct result of the restricted CDV
infection mentioned above remains to be shown.
The contribution of the immune response to early
lesion development is not clear. While an effective anti-
viral neutralizing immune response is lacking in the acute
phase of distemper, anti-CDV IgM antibodies occur within
the first 2 weeks of infection (Barben et al., 1999). Despite
severe immunosuppression and lack of perivascular cuff-
ing, numerous CD8+ cells are found in acute
demyelinating lesions and are diffusely distributed in the
brain parenchyma, roughly correlating with areas of viral
infection. In the cerebrospinal fluid (CSF) of such animals,
high titers of interleukin 8 are found (Tipold et al., 1999).
It has been suggested that initial macrophage/microglial
cell activation, which occurs in distemper (Alldinger et al.,
1996), may trigger invasion of T cells into the CNS (Tipold
et al., 1999). Antiviral cytotoxic immune reactions have
been shown only in the later stage of the disease (Appel
et al., 1982). It is uncertain, therefore, whether the invad-
ing cells have any effect on infected cells.
The chronic stage of distemper: immunopathological
complications
Coinciding with the recovery of the immune system,
perivascular cuffing with lymphocytes, plasma cells and
Canine distemper neuropathogenesis 5
Fig. 2. Canine distemper virus in the white matter of the
cerebellum demonstrated by in situ hybridization using a
probe specific for mRNA coding for the P-protein. Acute
phase of the disease.
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monocytes occurs in the initial virus-induced brain
lesions (Vandevelde et al., 1981). The inflammatory reac-
tion in the demyelinating lesions can lead to progression
of the tissue damage (Wisniewski et al., 1972;
Vandevelde et al., 1982b). There is often necrosis of the
tissue in such lesions, even though a significant number
of oligodendrocytes is still present in chronic, com-
pletely demyelinated lesions (Schobesberger et al.,
2002). Thus, the chronic stage of the disease is mainly
characterized by immunopathological complications.
It has been known for many years that anti-myelin
antibodies in serum occur in distemper (Krakowka et al.,
1973). We found such antibodies also in the CSF of dogs
with distemper, and that these antibodies are produced
locally in the inflammatory brain lesions (Vandevelde et
al., 1986). A cell-mediated response against myelin basic
protein was found in four of 11 dogs experimentally
infected with CDV (Cerruti Sola et al., 1983). However,
neither anti-myelin antibodies nor cell-mediated anti-
myelin reactions correlate with the course of the disease.
In addition, distemper has no resemblance to experi-
mental autoimmune encephalitis (Summers et al.,
1984b).
The initial intrathecal immune response in distemper
during the immunosuppressive stage of the disease con-
sists in diffuse invasion of CD8+ T cells (Tipold et al.,
1999). During immune recovery, a mature immune reac-
tion develops by perivascular infiltration of CD4+ cells
and subsequent recruitment of large numbers of plasma
cells and elevated antibody synthesis (Vandevelde et al.,
1981, 1986; Tipold et al., 1999; Wunschmann et al.,
1999). The titers of CDV-neutralizing antibodies in the
CSF often exceed those in the serum (Bollo et al., 1986).
Binding studies show that antibodies are made against
all proteins of CDV (Johnson et al., 1988). The occur-
rence of anti-CDV antibodies in the CSF coincided with
clearance of CDV and CDV-containing cells from the
inflammatory lesions (Bollo et al., 1986; Baumgärtner et
al., 1989; Alldinger et al., 1993b).
We found that antiviral antibodies bound to the sur-
face of CDV-infected cells interacted with the Fc
receptors of neighbouring macrophages by way of their
Fc portions (Bürge et al., 1989; Griot et al., 1989a, b).
This interaction resulted in a respiratory burst in
macrophages, with release of reactive oxygen species
(ROS). We could also show that stimulation of
macrophages by way of their Fc receptors or other
means, including antiviral antibody–virus immune com-
plexes, led to selective destruction of oligodendrocytes
in their vicinity (Griot et al., 1990; Griot-Wenk et al.,
1991; Botteron et al., 1992). These experiments showed
how the humoral antiviral immune response could lead
to destruction of oligodendrocytes as innocent bystander
cells (Griot et al., 1990). Obviously, several products
secreted by stimulated macrophages/microglia, including
ROS, can be made responsible for damage to the oligo-
dendrocyte/myelin compartment. ROS produced
chemically using the xanthine/xanthine oxidase system,
selectively damaged cultured oligodendrocytes when
added to the culture supernatant (Griot et al., 1990);
these cells are rich in transferrin and therefore contain a
considerable iron load (Griot and Vandevelde, 1988),
rendering them particularly vulnerable to ROS attacks.
The procoagulant activity of macrophages was markedly
enhanced after CDV infection (Brügger et al., 1992),
which may enhance the destructive potential of
macrophages and provide further support for the
hypothesis that bystander demyelination occurs in
chronic distemper. The experimental conditions in the
antibody experiments in vitro closely mimic the situation
in vivo, in which CDV-infected glial cells in the white
matter are in close contact with macrophages/microglia
and antiviral antibody-producing cells. Therefore, it is
not unreasonable to conclude that a bystander mecha-
nism associated with the antiviral immune response is
responsible for the progression of demyelinating lesions
in the chronic stage of CDV infection (Griot et al., 1990).
Further progression of the disease: virus persistence
The antiviral immune response should be beneficial to
the host insofar as CDV is removed from the tissue
(Bollo et al., 1986). However, our studies also showed
that CDV can persist in white matter areas outside the
inflammatory demyelinating lesions (Bollo et al., 1986).
It appears, therefore, that a chronic progressive disease
develops if the intrathecal immune response keeps lag-
ging behind viral replication. Thus, viral persistence
must be the key to the pathogenesis of the chronic
lesions. We found that persistent CDV spreads in a non-
cytolytic manner by way of cell processes with very
limited budding and release of infectious virus
(Zurbriggen et al., 1995) compared with attenuated
viruses. In addition, CDV is capable of producing
restricted infection in neurons without expressing viral
protein (Müller et al., 1995). Others have found restricted
expression of surface proteins in the CNS (Alldinger et
al., 1993a). Persistence of CDV appears to be related to
mechanism(s) preventing recognition of the virus by
immunocompetent cells. As sequencing studies have
shown differences between virulent and attenuated CDV
at the level of the NP, M, F and H genes (Stettler et al.,
1997; Cherpillod et al., 1999), it will be difficult to relate
persistence to single molecular determinants.
Prevention of CDV infection
Much has been learned about the development of the
CNS lesions in canine distemper. Some of these findings
may provide a basis for the development of therapeutic
strategies, in particular at the immunomodulatory level
and/or in reactivating oligodendrocytes from a progeni-
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tor pool, even in chronically demyelinated lesions
(Schobesberger et al., 2002). However, while modifica-
tion of the detrimental inflammatory response may
become feasible, the basic problem remains the pres-
ence of the virus in the CNS.
Effective antiviral therapies against morbilliviruses are
not available yet. Therefore, the most important veteri-
nary intervention remains prevention. Whereas vaccines
against CDV have been available for a long time and
have greatly reduced the incidence of the disease, avian-
ized strains offer inadequate protection against the
nervous form of CDV (Tipold et al., 1996), and other
vaccine strains may cause postvaccinal encephalitis
(Hartley, 1974; Cornwell et al., 1988). However, it is
most important to have significant information on dis-
ease pathogenesis before any therapeutic or preventive
approach is attempted.
It might be impossible to eradicate CDV because of its
global distribution and the wide variety of susceptible
wildlife species, which include marine and freshwater
seals, African cats and many others. Therefore, on the
basis of solid information on the pathogenesis of CDV,
the development of new preventive approaches, such as
the use of recombinant DNA vaccines, has been under-
taken. Recently, a DNA vaccine derived from virulent
CDV sequences was developed (Cherpillod et al., 2000).
Plasmids were constructed containing the nucleocapsid,
fusion protein and attachment protein genes of virulent
CDV. Preliminary studies have shown that this vaccine
induces both humoral and cellular immune response
against CDV antigens, and protects from virulent CDV
challenge (Cherpillod et al., 2000). Furthermore, the
immune response in puppies has been evaluated after
priming vaccination with CDV DNA followed by con-
ventional vaccination. The combination of the two
vaccines induced a strong humoral immune response
(unpublished results, C. Griot and A. Zurbriggen).
Conclusions
Novel morbilliviruses have emerged in recent years,
either as newly identified viruses or as viruses crossing
species barriers. The observation of morbilliviruses caus-
ing re-emerging and newly emerging diseases is
consistent with the fact that RNA viruses have a consid-
erable potential to mutate, and therefore can easily
adapt to new hosts within a short period (Domingo and
Holland, 1994; Cleaveland et al., 2001). CDV has been in
the carnivore population for many years and molecular
epidemiological evidence suggests that the virus has not
changed in the past.
Canine distemper is a well-studied member of the
Morbillivirus genus, and investigation of the pathogene-
sis of CDV infection might provide information as to the
pathogenesis of related viruses within the same family.
New morbillivirus-like viruses have shown zoonotic
potential and therefore are of relevance for public
health. There is a need for better preventive and diag-
nostic tools in the future because the vectors carrying
some of these viruses are also present in wildlife and
may hardly ever be eradicated (Daszak et al., 2000).
Thus, morbilliviruses continue to surprise us. With
new molecular techniques at hand and our present
knowledge of the disease mechanism of prototype
members of the Paramyxoviridae, we are in a better
position to rapidly identify, understand and design pre-
ventive or even therapeutic measures against them.
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